AU Patent

AU2021473165B2 — PHARMACEUTICAL COMPOSITION CONTAINING β-LACTAM COMPOUND AND USE THEREOF

Assigned to Guangzhou Hc New Drug Research Co Ltd · Expires 2025-05-22 · 1y expired

What this patent protects

The present invention relates to a pharmaceutical composition containing a β-lactam compound of formula (I), or a stereoisomer, a solvate or a pharmaceutically acceptable salt or ester thereof, and a lactamase inhibitor or efflux pump inhibitor, and the use thereof for resisting …

USPTO Abstract

The present invention relates to a pharmaceutical composition containing a β-lactam compound of formula (I), or a stereoisomer, a solvate or a pharmaceutically acceptable salt or ester thereof, and a lactamase inhibitor or efflux pump inhibitor, and the use thereof for resisting microorganisms, particularly bacteria, especially gram-negative bacteria, wherein each code in formula (I) is as defined in the description.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021473165B2
Jurisdiction
AU
Classification
—
Expires
2025-05-22
Drug substance claim
No
Drug product claim
No
Assignee
Guangzhou Hc New Drug Research Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.